Advances in the Treatment of Autism Spectrum Disorder : Current and Promising Strategies
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Autism spectrum disorder (ASD) is an umbrella term for developmental disorders characterized by social and communication impairments, language difficulties, restricted interests, and repetitive behaviors. Current management approaches for ASD aim to resolve its clinical manifestations based on the type and severity of the disability. Although some medications like risperidone show potential in regulating ASD-associated symptoms, a comprehensive treatment strategy for ASD is yet to be discovered. To date, identifying appropriate therapeutic targets and treatment strategies remains challenging due to the complex pathogenesis associated with ASD. Therefore, a comprehensive approach must be tailored to target the numerous pathogenetic pathways of ASD. From currently viable and basic treatment strategies, this review explores the entire field of advancements in ASD management up to cutting-edge modern scientific research. A novel systematic and personalized treatment approach is suggested, combining the available medications and targeting each symptom accordingly. Herein, summarize and categorize the most appropriate ways of modern ASD management into three distinct categories: current, promising, and prospective strategies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Current medicinal chemistry - 31(2024), 12 vom: 16., Seite 1485-1511 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yenkoyan, Konstantin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Animal model |
---|
Anmerkungen: |
Date Completed 05.04.2024 Date Revised 05.04.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/0109298673252910230920151332 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363808841 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363808841 | ||
003 | DE-627 | ||
005 | 20240405233158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0109298673252910230920151332 |2 doi | |
028 | 5 | 2 | |a pubmed24n1366.xml |
035 | |a (DE-627)NLM363808841 | ||
035 | |a (NLM)37888815 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yenkoyan, Konstantin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Advances in the Treatment of Autism Spectrum Disorder |b Current and Promising Strategies |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2024 | ||
500 | |a Date Revised 05.04.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Autism spectrum disorder (ASD) is an umbrella term for developmental disorders characterized by social and communication impairments, language difficulties, restricted interests, and repetitive behaviors. Current management approaches for ASD aim to resolve its clinical manifestations based on the type and severity of the disability. Although some medications like risperidone show potential in regulating ASD-associated symptoms, a comprehensive treatment strategy for ASD is yet to be discovered. To date, identifying appropriate therapeutic targets and treatment strategies remains challenging due to the complex pathogenesis associated with ASD. Therefore, a comprehensive approach must be tailored to target the numerous pathogenetic pathways of ASD. From currently viable and basic treatment strategies, this review explores the entire field of advancements in ASD management up to cutting-edge modern scientific research. A novel systematic and personalized treatment approach is suggested, combining the available medications and targeting each symptom accordingly. Herein, summarize and categorize the most appropriate ways of modern ASD management into three distinct categories: current, promising, and prospective strategies | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Autism spectrum disorder | |
650 | 4 | |a animal model | |
650 | 4 | |a management | |
650 | 4 | |a neurochemistry. | |
650 | 4 | |a neuropharmacology | |
650 | 4 | |a treatment strategy | |
700 | 1 | |a Ounanian, Zadik |e verfasserin |4 aut | |
700 | 1 | |a Mirumyan, Margarita |e verfasserin |4 aut | |
700 | 1 | |a Hayrapetyan, Liana |e verfasserin |4 aut | |
700 | 1 | |a Zakaryan, Naira |e verfasserin |4 aut | |
700 | 1 | |a Sahakyan, Raisa |e verfasserin |4 aut | |
700 | 1 | |a Bjørklund, Geir |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g 31(2024), 12 vom: 16., Seite 1485-1511 |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2024 |g number:12 |g day:16 |g pages:1485-1511 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0109298673252910230920151332 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2024 |e 12 |b 16 |h 1485-1511 |